Although not specifically required, consideration will begiven to those grant requests intended to demonstrate how theeducational initiative(s) will improve patient care by closing thegaps and assessing the healthcare providers' behavior relative tostandard of care and best available evidence....
Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis? Multiple sclerosis is an autoimmune treatable but not curable disease.There are a multiplicity of medications for multiple sclerosis therapy,including a cl... SFG Zorzella-Pezavento,LAN Mimura,MB Denadai...
may enable multiple sclerosis onset and progression (Thi Cuc et al., 2019). However, more studies are needed to understand the mechanism of the defective IL-10 production by B cells from multiple sclerosis patients, in order to adapt new therapeutic strategies and achieve positive outcomes. ...
Pathology of Multiple Sclerosis In subject area: Medicine and Dentistry The pathology of MS is characterized by myelin, oligodendrocytes and axonal loss in the brain, brain stem and spinal cord and by white matter lesions [1], resulting in heterogeneous and complex neurological deficits, including ...
Attempts to provide specific treatment for individuals with multiple sclerosis (MS) are mostly within the realm of immunotherapy. The word "specific" is somewhat misleading, since it implies sufficient understanding of the pathogenesis of MS to relate a specific action by a therapeutic agent to a ...
We also review the use of magnetic resonance imaging findings as an outcome measure in clinical trials assessing the efficacy of new therapeutic agents for the treatment of multiple sclerosis. More advanced applications of magnetic resonance imaging and their use in multiple sclerosis is addressed ...
Multiple sclerosis is a debilitating disease. An Italian study seems to offer a cure. Small wonder that sufferers are queuing for the operation that it suggests – and that some surgeons are offering to perform it and offer "liberation"– for a fee. But are the hopes and operations justified...
In the management of patients with multiple sclerosis (MS), providers are all faced with the highly formidable challenge of ascertaining whether, and to
sclerosis may also interfere with routine immunosurveillance functions of the central nervous system. Several additional targets for potential study and therapeutic intervention have been identified with the use of microarray techniques. For instance, this approach led to the discovery that osteopontin was ...
Multiple sclerosis (MS) is a neurodegenerative disorder caused by the immune system mistakenly attacking the myelin sheath, a protective coating around nerve fibers. This results in inflammation, which further damages the myelin sheath, as well as the nerve cells themselves and the cells that ...